Safety of Systemic Biologic Agents in the Treatment of Non-malignant Skin Disorders

E-ISSN： 2212-3911|12|2|76-94

ISSN： 1574-8863

Source： Current Drug Safety, Vol.12, Iss.2, 2017-07, pp. : 76-94

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Systemic use of non‐biologic agents in orofacial diseases: other immunomodulatory agents

ORAL DISEASES, Vol. 21, Iss. 3, 2015-04 ,pp. : 273-282

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biologic agents in the treatment of glomerulonephritides

NEPHROLOGY, Vol. 20, Iss. 11, 2015-11 ,pp. : 767-787

John Wiley & Sons Inc

Access to resources Recommend Favorite

NON‐MALIGNANT LESIONS CAUSING BLEEDING; DIAGNOSTIC PROCEDURE AND TREATMENT

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 1, Iss. 1, 1953-01 ,pp. : 17-29

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registry

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 5, 2015-05 ,pp. : 858-864

John Wiley & Sons Inc

Access to resources Recommend Favorite

Controlled-Release Oxycodone in the Treatment of Neuropathic Pain of Nonmalignant and Malignant Causes

Oncology, Vol. 74, Iss. 1, 2008-08 ,pp. : 72-75

Karger

Access to resources Recommend Favorite